Aspirin
A011502
Phase 3 small_molecule terminated
Quick answer
Aspirin for Node Positive HER2 Negative Breast Cancer is a Phase 3 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Node Positive HER2 Negative Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated